These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15647250)

  • 1. The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.
    Haché G; Liddament MT; Harris RS
    J Biol Chem; 2005 Mar; 280(12):10920-4. PubMed ID: 15647250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
    Langlois MA; Beale RC; Conticello SG; Neuberger MS
    Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
    Liddament MT; Brown WL; Schumacher AJ; Harris RS
    Curr Biol; 2004 Aug; 14(15):1385-91. PubMed ID: 15296757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.
    Holmes RK; Koning FA; Bishop KN; Malim MH
    J Biol Chem; 2007 Jan; 282(4):2587-95. PubMed ID: 17121840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle.
    Wang X; Dolan PT; Dang Y; Zheng YH
    J Biol Chem; 2007 Jan; 282(3):1585-94. PubMed ID: 17142455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins.
    Jónsson SR; Haché G; Stenglein MD; Fahrenkrug SC; Andrésdóttir V; Harris RS
    Nucleic Acids Res; 2006; 34(19):5683-94. PubMed ID: 17038330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
    Refsland EW; Hultquist JF; Harris RS
    PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
    Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.
    Zennou V; Bieniasz PD
    Virology; 2006 May; 349(1):31-40. PubMed ID: 16460778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.
    Nagao T; Yamashita T; Miyake A; Uchiyama T; Nomaguchi M; Adachi A
    J Med Invest; 2010 Feb; 57(1-2):89-94. PubMed ID: 20299747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC-mediated interference with hepadnavirus production.
    Rösler C; Köck J; Kann M; Malim MH; Blum HE; Baumert TF; von Weizsäcker F
    Hepatology; 2005 Aug; 42(2):301-9. PubMed ID: 16025511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
    Bishop KN; Holmes RK; Malim MH
    J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary function of the two catalytic domains of APOBEC3G.
    Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
    Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.
    Schumacher AJ; Nissley DV; Harris RS
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9854-9. PubMed ID: 16000409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
    Wichroski MJ; Robb GB; Rana TM
    PLoS Pathog; 2006 May; 2(5):e41. PubMed ID: 16699599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
    Kohli RM; Abrams SR; Gajula KS; Maul RW; Gearhart PJ; Stivers JT
    J Biol Chem; 2009 Aug; 284(34):22898-904. PubMed ID: 19561087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.
    Rathore A; Carpenter MA; Demir Ö; Ikeda T; Li M; Shaban NM; Law EK; Anokhin D; Brown WL; Amaro RE; Harris RS
    J Mol Biol; 2013 Nov; 425(22):4442-54. PubMed ID: 23938202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanine-adenine bias: a general property of retroid viruses that is unrelated to host-induced hypermutation.
    Müller V; Bonhoeffer S
    Trends Genet; 2005 May; 21(5):264-8. PubMed ID: 15851060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.